Patients with relapsing-remitting multiple sclerosis (MS) had fewer relapses after switching from glatiramer acetate to fingolimod versus remaining on the injectable disease-modifying therapy
Your search for evid returned 42 results
Use of lacosamide as the last antiepileptic drug (AED) a patient is administered for status epilepticus (SE) is “strongly associated with termination of status.”
Patients with active relapsing-remitting multiple sclerosis (MS) who had an inadequate response to one or more prior therapies at baseline showed durable improvement in clinical efficacy with alemtuzumab at 5 years.
For patients with medication overuse headaches, discontinuation of overused medication and addition of preventive medication offers the best current treatment, results presented at the 68th AAN Annual Meeting have found.
Monotherapy with tenofovir disoproxil fumarate (TDF) was equally effective as combination therapy with emtricitabine/TDF (FTC/TDF) in patients with chronic hepatitis B virus (HBV) infection harboring lamivudine resistance mutations, a study presented at The Liver Meeting® 2015 has found.
Drinking coffee might reduce the risk of alcoholic hepatitis (AH) among heavy alcohol drinkers, according to a study reported at The Liver Meeting® 2015
A non-TNF-targeted biologic showed better efficacy than a second anti-TNF agent for patients with rheumatoid arthritis and insufficient response to TNF-inhibitors, according to research presented at the 2015 ACR/ARHP Annual Meeting.
Patients with active psoriatic arthritis who were biologic disease-modifying antirheumatic drug (bDMARD)-naive had significantly improved quality of life, physical function, and work productivity following treatment with ixekizumab, investigators reported at the 2015 ACR/ARHP Annual Meeting.
Patients with rheumatoid arthritis (RA) who initiate TNF inhibitor therapy have an increased risk of tuberculosis, with the highest risk of incidence within the first 6 months, researchers concluded at the 2015 ACR/ARHP Annual Meeting.
Treatment with hyaluronic acid (HA) for elderly patients with knee osteoarthritis (OA) is associated with significantly longer delay to knee arthroplasty (KA), according to Roy D. Altman, MD, Professor of Medicine at the David Geffen School of Medicine at UCLA, Los Angeles, CA, at the 2015 ACR/ARHP Annual Meeting.